Datalec Precision Installations (DPI) Announces Wholly Owned ACCS Manufacturing Plant
Datalec Precision Installations (DPI), a provider of world-class data centre design, supply, build, and support services to deliver seamless, integrated and unified end-to-end solutions for data centre operators, announces its latest investment in a wholly owned subsidiary, managed by Yuriy Vasylkivskyy, that will deliver hot and cold aisle containment and caging solutions to the data centre industry. This solely owned and operated manufacturing facility is 35,000 square feet and is designed to operate 24/7 based on increasing demand for data centre components.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211012005077/en/
Datalec's Aerial Photo of the ACCS Manufacturing plant for aisle containment and cage solutions located in the UK (Photo: Business Wire)
Datalec’s ACCS manufacturing has been constructing metal cages and proprietary hot and cold aisle containment solutions and other specialist components. Originally performing an ‘assemble onsite’ facility, Datalec’s manufacturing plant has progressed into a fully-fledged offsite design, manufacturing and construction facility. The facility can efficiently produce prefabricated components and pre-terminated cables which can then be delivered to data centres throughout Europe for final on-site construction. Europe has seen a tremendous growth in data centre development causing the demand in data centre components to rise. The constraints in the supply chain significantly impact the building process and affect the European data centre market. Datalec’s investment directly addresses supply chain challenges, improving delivery timeframes and giving much needed momentum to the industry.
The ACCS manufacturing plant has profound benefits for Datalec’s business and supports the European data centre market well. As it relates to larger projects, it can lessen the overall impact of a supply chain known to be under pressure. By purchasing in advance raw materials required in data centre fit out projects, anticipating commodity price fluctuations and managing the product cost accordingly for end-users, ACCS can add significant value. Core to Datalec’s values is the constant pursuit of perfection and customer satisfaction is paramount. Responding to client demands, there are plans underway to construct a powder coating line further ensuring an output quality of the highest possible level.
For more information about DPI’s ACCS Manufacturing Plant, please visit https://datalecltd.co.uk/.
About Datalec
Datalec Precision Installations delivers excellence in international data centre installations, partnering with clients to make their businesses successful while providing seamless, integrated, unified end-to-end results with a ‘One Call, One Team’ service. DPI’s rigorous project management and supervision ensures projects are implemented to perfection the first time, every time, while mitigating risk and reducing cost for clients. DPI is focused on delivering a proactive and personal service that provides agility, flexibility and adaptability for substantial data suite construction and implementations. For more information visit: https://datalecltd.co.uk/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211012005077/en/
Contact information
Media Contact
Ilissa Miller
iMiller Public Relations
Email: datalec@imillerpr.com
Tel: 1.914.315.6424
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Quectel Unveils Advanced Matter over Thread Modules for Seamless Device Interoperability13.11.2025 11:00:00 EET | Press release
Quectel Wireless Solutions, an end-to-end global IoT solutions provider, today announced the launch of the KGM133S, the first in a range of Matter over Thread modules that provides innovative solutions for applications such as smart door locks, sensors, and lighting, helping the smart home industry overcome connectivity barriers and advance toward a new era of more efficient and seamless development. The KGM133S series modules are built based on the Silicon Labs EFR32MG24 chip, supporting the latest Matter 1.4 protocol. The modules are designed to enable seamless linkage of home devices across ecosystems, including Apple Home, Google Home, Amazon Alexa and Samsung SmartThings. “Protocol fragmentation remains one of the biggest obstacles to seamless smart device connectivity, and the Matter protocol is the key to overcoming it,” said Delbert Sun, Deputy General Manager at Quectel Wireless Solutions. “With our new Matter over Thread modules, we are helping the industry achieve true inter
SBC Medical Group Announces Commencement of Tender Offer for Shares of Waqoo, Inc.13.11.2025 10:57:00 EET | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced that on November 13, 2025, SBC Medical Group Co., Ltd. (the “Tender Offeror”) has resolved to acquire shares of common stock of Waqoo, Inc. (Securities Code: 4937, listed on the Tokyo Stock Exchange Growth Market; the “Target Company”) through a tender offer (the “Tender Offer”) pursuant to the Financial Instruments and Exchange Act of Japan (Act No. 25 of 1948, as amended; the “FIEA”), as described below. The Tender Offeror is a Japanese subsidiary ultimately owned by SBC Medical Group Holdings Incorporated (“SBCHD”), a U.S. corporation listed on NASDAQ and engaged in management support services for medical clinics both domestically and internationally. As of today, the Tender Offeror holds 353,600 shares of the Target Company’s common stock (ownership ratio: 9.49%).
IQM Launches Halocene, a New Quantum Computer Product Line for Error Correction13.11.2025 10:56:00 EET | Press release
IQM Quantum Computers, a global leader in superconducting quantum computers, today announced the launch of its new product line called IQM Halocene. The new product line is based on open and modular on-premises quantum computers designed for quantum error correction research, a leap towards the next generation of quantum computers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251113614564/en/ The first release of IQM Halocene will be a 150-qubit quantum computer with advanced error correction functionality. The system will enable users to advance their error correction capabilities, error correction research and to create intellectual property with logical qubits. In addition, the Halocene product line will allow execution of Noisy Intermediate Scale (NISQ) algorithms and the development of error mitigation techniques. “Halocene is the result of co-developing our technology stack with our partners and customers as we build
JSR Life Sciences Enters Definitive Agreement to Transfer Crown Bioscience to Adicon Holdings Limited13.11.2025 10:45:00 EET | Press release
JSR Life Sciences LLC ("JSR Life Sciences"), a global leader in life sciences materials and services, today announced it has entered into a definitive agreement to transfer Crown Bioscience Inc. ("Crown Bioscience") to Adicon Holdings Limited ("Adicon"), a premier independent clinical laboratory provider in China and a portfolio company of The Carlyle Group. The transaction, subject to customary closing conditions, is expected to close in 2026. This strategic move will enable Crown Bioscience to operate as a standalone entity under Adicon's ownership. Crown Bioscience's comprehensive portfolio of translational oncology services, including its world-leading patient-derived xenograft (PDX) models, tumor organoid platforms, immuno-oncology assays, and bioinformatics solutions, will transition to Adicon, positioning the company to accelerate advancements in precision medicine and drug discovery for oncology. Crown Bioscience's Global Biospecimens business, headquartered in Hamburg, Germany
Ohmium Breaks Barriers: Exceeds 2030 Industry Targets of 10 GW/ton to Achieve 18 GW/ton Iridium Utilization13.11.2025 10:05:00 EET | Press release
Ohmium International Inc., a leading provider of cutting-edge, high-efficiency, and modular Proton Exchange Membrane (PEM) electrolyzers, has surpassed the PEM electrolyzer industry's 2030 target of 10 GW per ton to attain an 18 GW per ton iridium utilization rate. Ohmium has made significant technological advancements which have resulted in reducing its iridium usage by 50% in its Lotus electrolyzer, Mark 2. This enhances the cost-competitiveness of green hydrogen production by reducing the overall cost of its PEM electrolyzers, which have been impacted by the cost of the precious metal, iridium. Dr. Chock Karuppaiah, Ohmium Chief Science and Technology Officer, said, "We've made significant strides in reducing iridium usage in our PEM electrolyzers, exceeding the 2030 industry target of 10 GW per ton. We've achieved a utilization rate of 18 GW per ton. This innovation is crucial, as iridium is one of the most expensive materials in electrolyzer manufacturing.” Dr. Markus Tacke, Ohmiu
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom